Operating Margin in % of Talis Biomedical Corp from 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Talis Biomedical Corp quarterly/annual Operating Margin history and change rate from 2021 to Q2 2024.
  • Talis Biomedical Corp Operating Margin for the quarter ending 30 Jun 2024 was -13.5K %, a 327% decline year-over-year.
  • Talis Biomedical Corp annual Operating Margin for 2023 was -3.13K %, a 30.9% decline from 2022.
  • Talis Biomedical Corp annual Operating Margin for 2022 was -2.39K %, a 2.2% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Talis Biomedical Corp Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2024 -13.5K -10.3K -327% 01 Apr 2024 30 Jun 2024
Q1 2024 -6.26K -2.7K -76% 01 Jan 2024 31 Mar 2024
Q4 2023 -3.13K -738 -30.9% 01 Oct 2023 31 Dec 2023
Q3 2023 -3.66K -1.53K -71.7% 01 Jul 2023 30 Sep 2023
Q2 2023 -3.17K -535 -20.4% 01 Apr 2023 30 Jun 2023
Q1 2023 -3.56K +192 +5.11% 01 Jan 2023 31 Mar 2023
Q4 2022 -2.39K -51.5 -2.2% 01 Oct 2022 31 Dec 2022
Q3 2022 -2.13K 01 Jul 2022 30 Sep 2022
Q2 2022 -2.63K 01 Apr 2022 30 Jun 2022
Q1 2022 -3.75K 01 Jan 2022 31 Mar 2022
Q4 2021 -2.34K 01 Oct 2021 31 Dec 2021

Talis Biomedical Corp Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2023 -3.13K -738 -30.9% 01 Jan 2023 31 Dec 2023
2022 -2.39K -51.5 -2.2% 01 Jan 2022 31 Dec 2022
2021 -2.34K 01 Jan 2021 31 Dec 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.